Find Research Projects

Search results

• Active

  National Biocontainment Laboratories Operations Support

  Urban, R.

  4/1/21 → 5/31/26

  Project: Other project

• RSVP - Federal 21SRGTX002

  Volpi, E.

  Corporation for National & Community Ser

  4/1/21 → 3/31/24

  Project: Other project

• Subk: University of Michigan

  Stevenson-Lerner, H.

  4/1/21 → 3/31/26

  Project: Other project

• Muruato (pre-doc)

  Hommel, J.

  4/1/21 → 3/31/25

  Project: Other project

• Sattler (pre-doc)

  Hommel, J.

  4/1/21 → 3/31/25

  Project: Other project

• EFRI CEE: Opening the Gates of Apoptosis in Cancer

  Motamedi, M.

  4/1/21 → 12/31/23

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• National Biocontainment Laboratories Operations Support

  Urban, R.

  National Inst of Allergy & Infectious Di

  4/1/21 → 5/31/26

  Project: Other project

• Subk: M D Anderson

  Stevenson-Lerner, H.

  4/1/21 → 3/31/26

  Project: Other project

• Manning (post-doc)

  Hommel, J.

  4/1/21 → 3/31/25

  Project: Other project

• Maternal-Fetal Medicine Units Network

  Saade, G.

  4/1/21 → 3/31/25

  Project: Other project

• Option 12.2B: SAVE- Variant Pipeline-Competition Studies (MOD 2)

  Shi, P.

  4/1/21 → 3/31/23

  Project: Other project

• Science-based Habit Formation app as an adjunct to the National Diabetes Prevention Program (DPP) Lifestyle Change Program (LCP) to increase engagement, participation, and outcomes of underserved populations and others eligible for the DPP LCP

  Sallam, H.

  3/29/21 → 3/28/23

  Project: Other project

• PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTH

  Rupp, R.

  3/29/21 → 3/28/26

  Project: Other project

• PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTH

  Rupp, R.

  Pfizer, Inc.

  3/29/21 → 3/28/26

  Project: Other project

• Science-based Habit Formation app as an adjunct to the National Diabetes Prevention Program (DPP) Lifestyle Change Program (LCP) to increase engagement, participation, and outcomes of underserved populations and others eligible for the DPP LCP

  Sallam, H.

  Fresh Tri Inc

  3/29/21 → 3/28/23

  Project: Other project

• Preclinical Study for the Evaluation of the Xpert GI Panel

  Ren, P.

  Cepheid

  3/29/21 → 3/28/23

  Project: Other project

• Colombia-U.S. Fogarty training program on the impact of emerging zoonotic and vector-borne diseases in acute undifferentiated febrile illnesses

  Aguilar, P.

  Fogarty International Center

  3/15/21 → 2/28/26

  Project: Other project

• Subk - University of Antioquia Colombia

  Aguilar, P.

  3/15/21 → 2/28/26

  Project: Other project

• AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation

  Cisneros, I.

  National Inst on Drug Abuse

  3/15/21 → 2/28/26

  Project: Other project

• Subk - Yale University

  Aguilar, P.

  3/15/21 → 2/28/26

  Project: Other project

• Molecular Characterization of Transmissible Chromosome Aberrations Produced by Ions of Intermediate and High Atomic Number

  Cornforth, M.

  NASA Johnson Space Center

  3/11/21 → 3/10/24

  Project: Other project

• Subk-UTSW

  Cornforth, M.

  3/11/21 → 3/10/24

  Project: Other project

• A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

  Rupp, R.

  Pfizer, Inc.

  3/11/21 → 3/10/25

  Project: Other project

• A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

  Rupp, R.

  3/11/21 → 3/10/25

  Project: Other project

• Preclinical development of a vaccine for Nipah virus

  Geisbert, T.

  National Inst of Allergy & Infectious Di

  3/11/21 → 2/28/26

  Project: Other project

• SubK - Integrated Biotherapeutics, Inc.

  Geisbert, T.

  3/11/21 → 2/28/26

  Project: Other project

• Re: A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

  Rupp, R.

  3/11/21 → 3/10/25

  Project: Other project

• 1042-SE-3003 A double-blind randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus

  Dabi, A.

  3/4/21 → 3/3/24

  Project: Other project

• Bao - IHII COVID-19

  Weaver, S.

  3/2/21 → 4/14/23

  Project: Other project

• Wang - IHII COVID-19

  Weaver, S.

  3/2/21 → 4/14/23

  Project: Other project

• Goodman - IHII COVID-19

  Weaver, S.

  3/2/21 → 4/14/23

  Project: Other project

• Identifying structural and transcriptional signatures of abnormal chromosomes in single cells

  Nir, G.

  3/1/21 → 2/28/26

  Project: Other project

• Mechanisms of Synaptic Protection in Cognitive Resilience to Alzheimer's Disease Neuropathology

  Limon-Ruiz, A.

  National Inst on Aging

  3/1/21 → 2/28/26

  Project: Other project

• Subk - Baylor College of Medicine

  Nir, G.

  3/1/21 → 2/28/26

  Project: Other project

• Mechanisms of Synaptic Protection in Cognitive Resilience to Alzheimer's Disease Neuropathology

  Limon-Ruiz, A.

  National Inst on Aging

  3/1/21 → 2/28/26

  Project: Other project

• (Pfizer Pregnant COVID Vaccine C4591015) A PHASE 2/3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS COV 2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID 19 IN HEALTHY PREGNANT WOME

  Saade, G.

  2/10/21 → 2/9/26

  Project: Other project

• (Pfizer Pregnant COVID Vaccine C4591015) A PHASE 2/3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS COV 2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID 19 IN HEALTHY PREGNANT WOME

  Saade, G.

  Pfizer, Inc.

  2/10/21 → 2/9/26

  Project: Other project

• Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models (resubmission of AI53524)

  Chopra, A.

  National Inst of Allergy & Infectious Di

  2/1/21 → 7/31/25

  Project: Other project

• Infectious Diseases and Inflammatory Disorders Training Program

  Wang, T.

  National Inst of Allergy & Infectious Di

  2/1/21 → 1/31/26

  Project: Other project

• A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

  Rupp, R.

  Merck Sharp & Dohme Corporation

  1/29/21 → 1/28/26

  Project: Other project

• Starling Registry Study

  Saad, A.

  1/29/21 → 1/28/26

  Project: Other project

• Starling Registry Study

  Saad, A.

  Baxter Healthcare Corporation-Irvine

  1/29/21 → 1/28/26

  Project: Other project

• A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

  Rupp, R.

  1/29/21 → 1/28/26

  Project: Other project

• A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction e 40% (L

  Khalife, W.

  1/21/21 → 1/20/26

  Project: Other project

• A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction e 40% (L

  Khalife, W.

  Bayer HealthCare Pharmaceuticals

  1/21/21 → 1/20/26

  Project: Other project